LAVA Therapeutics N.V. (LVTX) Tops Q1 EPS by 19c

LAVA Therapeutics N.V. (NASDAQ: LVTX) reported Q1 EPS of ($0.13), $0.19 better than the analyst estimate of ($0.32).

For earnings history and earnings-related data on LAVA Therapeutics N.V. (LVTX) click here.

You May Also Be Interested In

• Anthropic Signs $35b Cloud Deal With Lambda In Texas: WSJ
• Reliance Industries (RELIANCE:IN) PT Raised to INR1,710 at Jefferies
• Morgan Stanley Upgrades DNB ASA (DNB:NO) (DNHBY) to Equalweight